BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31695072)

  • 1. Improved Cas9 activity by specific modifications of the tracrRNA.
    Scott T; Urak R; Soemardy C; Morris KV
    Sci Rep; 2019 Nov; 9(1):16104. PubMed ID: 31695072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic Circular Dichroism of the Cas9 Protein and gRNA:Cas9 Ribonucleoprotein Complex.
    Halat M; Klimek-Chodacka M; Orleanska J; Baranska M; Baranski R
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
    Briner AE; Henriksen ED; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.
    Li C; Guan X; Du T; Jin W; Wu B; Liu Y; Wang P; Hu B; Griffin GE; Shattock RJ; Hu Q
    J Gen Virol; 2015 Aug; 96(8):2381-2393. PubMed ID: 25854553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key sequence features of CRISPR RNA for dual-guide CRISPR-Cas9 ribonucleoprotein complexes assembled with wild-type or HiFi Cas9.
    Okada K; Aoki K; Tabei T; Sugio K; Imai K; Bonkohara Y; Kamachi Y
    Nucleic Acids Res; 2022 Mar; 50(5):2854-2871. PubMed ID: 35166844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR-Cas9 genome engineering of primary CD4
    Hultquist JF; Hiatt J; Schumann K; McGregor MJ; Roth TL; Haas P; Doudna JA; Marson A; Krogan NJ
    Nat Protoc; 2019 Jan; 14(1):1-27. PubMed ID: 30559373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes.
    Camperi J; Moshref M; Dai L; Lee HY
    Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4
    Xiao Q; Chen S; Wang Q; Liu Z; Liu S; Deng H; Hou W; Wu D; Xiong Y; Li J; Guo D
    Retrovirology; 2019 Jun; 16(1):15. PubMed ID: 31186067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified sgRNAs.
    Holmgaard AB; Askou AL; Jensen EG; Alsing S; Bak RO; Mikkelsen JG; Corydon TJ
    Mol Ther; 2021 Jan; 29(1):191-207. PubMed ID: 33022212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-free protein synthesis of CRISPR ribonucleoproteins (RNP).
    McGaw C; Chong S
    Methods Enzymol; 2021; 659():371-389. PubMed ID: 34752296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heavily and fully modified RNAs guide efficient SpyCas9-mediated genome editing.
    Mir A; Alterman JF; Hassler MR; Debacker AJ; Hudgens E; Echeverria D; Brodsky MH; Khvorova A; Watts JK; Sontheimer EJ
    Nat Commun; 2018 Jul; 9(1):2641. PubMed ID: 29980686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guide RNAs: A Glimpse at the Sequences that Drive CRISPR-Cas Systems.
    Briner AE; Barrangou R
    Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome editing with CRISPR/Cas9 in Pinus radiata (D. Don).
    Poovaiah C; Phillips L; Geddes B; Reeves C; Sorieul M; Thorlby G
    BMC Plant Biol; 2021 Aug; 21(1):363. PubMed ID: 34376154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Assembly of CRISPR/Cas9 Lentiviral and rAAV Vectors for Targeted Genome Editing.
    Sandoval IM; Collier TJ; Manfredsson FP
    Methods Mol Biol; 2019; 1937():29-45. PubMed ID: 30706388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The initiation, propagation and dynamics of CRISPR-SpyCas9 R-loop complex.
    Zeng Y; Cui Y; Zhang Y; Zhang Y; Liang M; Chen H; Lan J; Song G; Lou J
    Nucleic Acids Res; 2018 Jan; 46(1):350-361. PubMed ID: 29145633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Efficient Expression and Purification Protocol for SpCas9 Nuclease and Evaluation of Different Delivery Methods of Ribonucleoprotein.
    Evmenov K; Pustogarov N; Panteleev D; Safin A; Alkalaeva E
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered exosome for delivering sgRNA:Cas9 ribonucleoprotein complex and genome editing in recipient cells.
    Ye Y; Zhang X; Xie F; Xu B; Xie P; Yang T; Shi Q; Zhang CY; Zhang Y; Chen J; Jiang X; Li J
    Biomater Sci; 2020 May; 8(10):2966-2976. PubMed ID: 32342086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.